- Home
- ELOG vs VRCA Comparison
ELOG vs VRCA Comparison
Compare ELOG & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELOG
- VRCA
- Stock Information
- Founded
- ELOG 2006
- VRCA 2013
- Country
- ELOG China
- VRCA United States
- Employees
- ELOG N/A
- VRCA N/A
- Industry
- ELOG Integrated Freight & Logistics
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- ELOG Industrials
- VRCA Health Care
- Exchange
- ELOG Nasdaq
- VRCA Nasdaq
- Market Cap
- ELOG 30.4M
- VRCA 32.7M
- IPO Year
- ELOG 2025
- VRCA 2018
- Fundamental
- Price
- ELOG $2.22
- VRCA $3.73
- Analyst Decision
- ELOG
- VRCA Hold
- Analyst Count
- ELOG 0
- VRCA 2
- Target Price
- ELOG N/A
- VRCA N/A
- AVG Volume (30 Days)
- ELOG 15.9K
- VRCA 117.5K
- Earning Date
- ELOG 11-28-2025
- VRCA 11-14-2025
- Dividend Yield
- ELOG N/A
- VRCA N/A
- EPS Growth
- ELOG 60.00
- VRCA N/A
- EPS
- ELOG 0.16
- VRCA N/A
- Revenue
- ELOG $40,041,691.00
- VRCA $30,829,000.00
- Revenue This Year
- ELOG N/A
- VRCA $332.45
- Revenue Next Year
- ELOG N/A
- VRCA $12.85
- P/E Ratio
- ELOG $14.19
- VRCA N/A
- Revenue Growth
- ELOG N/A
- VRCA 234.73
- 52 Week Low
- ELOG $1.82
- VRCA $3.28
- 52 Week High
- ELOG $3.60
- VRCA $13.60
- Technical
- Relative Strength Index (RSI)
- ELOG N/A
- VRCA 47.73
- Support Level
- ELOG N/A
- VRCA $3.37
- Resistance Level
- ELOG N/A
- VRCA $4.02
- Average True Range (ATR)
- ELOG 0.00
- VRCA 0.27
- MACD
- ELOG 0.00
- VRCA 0.07
- Stochastic Oscillator
- ELOG 0.00
- VRCA 70.07
About ELOG Eastern International Ltd. Ordinary Shares
Eastern International Ltd is a holding company. The company operates through its subsidiary engaged in domestic and cross-border professional logistic services including project logistics and general logistics for company clients. Its project logistic services include Construction project logistics and special cargo logistics for large or precision equipment and General logistic services refer to the transportation, warehousing, loading and unloading, and distribution of ordinary products. Its segments are Transportation services and Warehouse subleasing services. The group generates the majority of its revenue from Transportation services.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.